Evaluation of variable p16 immunostaining patterns, Ki-67 indices and HPV status in cervical SILs and squamous cell carcinomas: An institutional experience

被引:4
作者
Singh, Priti [1 ]
Kaushik, Sanjay [1 ]
Thakur, Brijesh [1 ,2 ]
Acharya, Seema [1 ]
Bhardwaj, Aparna [1 ]
Bahal, Neelima [1 ]
机构
[1] Shri Guru Ram Rai Inst Med & Hlth Sci, Dept Pathol, Dehra Dun, Uttarakhand, India
[2] SGRRIM & HS, Dept Pathol, Dehra Dun 248001, Uttarakhand, India
关键词
Cervix; HPV; p16; ki-67; SIL; SCC; HPV-16/18 AS04-ADJUVANTED VACCINE; HUMAN-PAPILLOMAVIRUS INFECTION; OF-STUDY ANALYSIS; INTRAEPITHELIAL NEOPLASIA; CANCER; EXPRESSION; P16(INK4A); RISK; EFFICACY; PROTEIN;
D O I
10.4103/ijpm.ijpm_656_21
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: The present study evaluates the immunoexpression of p16 and Ki-67 in cervical squamous intraepithelial lesion (SIL) and carcinomas and correlates their expression with clinicopathological features and HPV-DNA status. Material and Methods: A total 36 included cases of SIL and squamous cell carcinoma (SCC) were subjected to p16 and Ki-67 immunostaining. p16 staining was evaluated depending on grading, distribution, localization pattern, intensity and IHC score. Ki-67 expression was graded based on percentage of positive cells. Results: Incidence of HSIL and SCC cases was found to be significantly increased with parity > 5. p16 grade III diffuse nucleocytoplasmic immunostaining was observed in 62.5% LSIL, 80% HSIL and 87% SCC cases. Significant association of p16 staining intensity, IHC score and Ki-67 indices was noted with increasing grades of SILs and carcinomas. Conclusion: Our experience indicates that a combination of p16 and Ki-67 immunostaining may be useful to determine the severity of dysplastic change.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 28 条
[11]  
Kishore V, 2017, J CLIN DIAGN RES, V11, pEC17, DOI 10.7860/JCDR/2017/29394.10644
[12]   Overexpression of p16ink4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri [J].
Klaes, R ;
Friedrich, T ;
Spitkovsky, D ;
Ridder, R ;
Rudy, W ;
Petry, U ;
Dallenbach-Hellweg, G ;
Schmidt, D ;
Doeberitz, MV .
INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (02) :276-284
[13]   Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia [J].
Krishnappa, Purushotham ;
Mohamad, Ibtisam Binti ;
Lin, Yip Jo ;
Barua, Ankur .
DIAGNOSTIC PATHOLOGY, 2014, 9
[14]   Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial [J].
Lehtinen, Matti ;
Paavonen, Jorma ;
Wheeler, Cosette M. ;
Jaisamrarn, Unnop ;
Garland, Suzanne M. ;
Castellsague, Xavier ;
Skinner, S. Rachel ;
Apter, Dan ;
Naud, Paulo ;
Salmeron, Jorge ;
Chow, Song-Nan ;
Kitchener, Henry ;
Teixeira, Julio C. ;
Hedrick, James ;
Limson, Genara ;
Szarewski, Anne ;
Romanowski, Barbara ;
Aoki, Fred Y. ;
Schwarz, Tino F. ;
Poppe, Willy A. J. ;
De Carvalho, Newton S. ;
Germar, Maria Julieta V. ;
Peters, Klaus ;
Mindel, Adrian ;
De Sutter, Philippe ;
Xavier Bosch, F. ;
David, Marie-Pierre ;
Descamps, Dominique ;
Struyf, Frank ;
Dubin, Gary .
LANCET ONCOLOGY, 2012, 13 (01) :89-99
[15]   Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection:: the IARC multicentric case-control study [J].
Moreno, V ;
Bosch, FX ;
Muñoz, N ;
Meijer, CJLM ;
Shah, DV ;
Valboomers, JMM ;
Herrero, R ;
Franceschi, S .
LANCET, 2002, 359 (9312) :1085-1092
[16]   P16INK4A positivity in benign, premalignant and malignant cervical glandular lesions:: a potential diagnostic problem [J].
Murphy, N ;
Heffron, CCBB ;
King, B ;
Ganuguapati, UG ;
Ring, M ;
McGuinness, E ;
Sheils, O ;
O'Leary, JJ .
VIRCHOWS ARCHIV, 2004, 445 (06) :610-615
[17]  
Nam Eun Ji, 2008, J Gynecol Oncol, V19, P162, DOI 10.3802/jgo.2008.19.3.162
[18]  
Poste P, 2015, Int Ann Adv Sci Res, V2, P51
[19]   P16INK4a expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions [J].
Queiroz, C ;
Silva, TC ;
Alves, VAF ;
Villa, LL ;
Costa, MC ;
Travassos, AG ;
Araújo, JB ;
Studart, E ;
Cheto, T ;
de Freitas, LAR .
PATHOLOGY RESEARCH AND PRACTICE, 2006, 202 (02) :77-83
[20]   Human Papillomavirus Testing in the Prevention of Cervical Cancer [J].
Schiffman, Mark ;
Wentzensen, Nicolas ;
Wacholder, Sholom ;
Kinney, Walter ;
Gage, Julia C. ;
Castle, Philip E. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (05) :368-383